Open original FDA record ↗Recall record
- FDA identifier
- Z-1728-2020
- Company in FDA record
- Abbott Gmbh & Co. KG
- FDA record creation date
- Apr 17, 2020
- First observed by MedTech Watch
- Nov 16, 2026
- Latest observed content change
- Nov 16, 2026
- Recall classification
- Class II
Reason stated in the source
An erroneous concentration value for hepatitis A virus was utilized during manufacture, leading to a decreased amount of antigen used for the impacted lots.
Source facts
- Action
- Abbott GmbH notified customers on 03/09/2020 via "Product Recall Urgent Immediate Action Required" letter. The recall letter identified the affected products and requested the customers to Immediately discontinue use of, and destroy, any remaining inventory of these ARCHITECT HAVABG reagent lots.
- Initiated
- 2020-03-09
- Root cause
- Mixed-up of materials/components
- Terminated
- 2021-02-11
- Distribution
- US nationwide including the states of AL, AR, AZ, CA, CO, CT DE, FL, GA, ID, IL, KS, KY, LA, MA, MD, MI, MN, MO, MS, NC, NH, NJ, NM NV, NY, OH, OK, OR, PA, RH, SC, TN, TZ, UT, VA, WA, WI, WV AND PR.
- Recall number
- Z-1728-2020
- Recall status
- Terminated
- CDRH record ID
- 180348
- FDA record created
- 2020-04-17
- Recall event number
- 85238